4.6 Article

Network medicine, multimorbidity and the Lung in the elderly

Journal

EUROPEAN RESPIRATORY JOURNAL
Volume 44, Issue 3, Pages 775-788

Publisher

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00078714

Keywords

-

Funding

  1. FIS [12/01117]
  2. SEPAR [192/2012]
  3. BECA FUCAP
  4. BECA SEPAR [065/2013]
  5. RESERCAIXA
  6. [2014FIB00417]
  7. [BEI-2012-66]

Ask authors/readers for more resources

Noncommunicable diseases, including cardiovascular, metabolic and respiratory diseases, among others, are the major medical challenge of the 21st century. Most noncommunicable diseases are related to the ageing process and often co-occur in the same individual. However, it is unclear whether the index disease is somehow influencing the development of the other ones (comorbidity) or whether all of them (including the index disease) simply represent the clinical expression of pathological ageing (multimorbidity). The pathobiology of ageing, chronic obstructive pulmonary disease (COPD) and concomitant disorders is complex. A new field of research, known as systems biology if applied to model systems or network medicine if applied to human beings, has emerged over the past decade or so, to address biological complexity in a holistic, integrated way. It offers, therefore, great potential to decipher the relationship between ageing, COPD and comorbidities/multimorbidities. In this State of the Art review we present the basic concepts of systems biology, use some examples to illustrate the potential of network medicine to address complex medical problems, and review some recent publications that show how a systems-based research strategy can contribute to improve our understanding of multimorbidity and age-related respiratory diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Critical Care Medicine

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

Tessa M. Kole, Elise Vanden Berghe, Monica Kraft, Judith M. Vonk, Martijn C. Nawijn, Salman Siddiqui, Kai Sun, Leonardo M. Fabbri, Klaus F. Rabe, Kian Fan Chung, Gabriele Nicolini, Alberto Papi, Chris Brightling, Dave Singh, Thys van der Molen, Sven-Erik Dahlen, Alvar Agusti, Rosa Faner, Jadwiga A. Wedzicha, Gavin C. Donaldson, Ian M. Adcock, Lies Lahousse, Huib A. M. Kerstjens, Maarten van den Berge

Summary: This post-hoc analysis investigates the determinants, clinical implications, and outcome of persistent airflow limitation (PAL) in patients with asthma. The study reveals that PAL is not only present in severe asthma, but also in a considerable proportion of patients with milder disease. In patients with mild asthma, PAL is associated with eosinophilic inflammation and a higher risk of exacerbations, suggesting the need for increased treatment intensity.

LANCET RESPIRATORY MEDICINE (2023)

Letter Critical Care Medicine

Circulating Biomarkers in Young Individuals with Low Peak FEV1

Nuria Olvera, Sandra Casas, Judith M. Vonk, Tamara Garcia, H. Marike Boezen, Maarten van den Berge, Alvar Agusti, Rosa Faner

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Respiratory System

Lung function in young adults born small for gestational age at term

Kilian Vellve, Alvaro Sepulveda-Martinez, Merida Rodriguez-Lopez, Francesca Crovetto, Gabriel Bernardino, Felip Burgos, Rosa Faner, Alvar Agusti, Bart Bijnens, Eduard Gratacos, Fatima Crispi, Isabel Blanco

RESPIROLOGY (2023)

Article Critical Care Medicine

Plasticity of Individual Lung Function States from Childhood to Adulthood

Gang Wang, Jenny Hallberg, Rosa Faner, Hans-Jacob Koefoed, Simon Kebede Merid, Susanna Klevebro, Sophia Bjorkander, Olena Gruzieva, Goran Pershagen, Marianne van Hage, Stefano Guerra, Matteo Bottai, Antonios Georgelis, Ulrike Gehring, Anna Bergstrom, Judith M. Vonk, Inger Kull, Gerard H. Koppelman, Alvar Agusti, Erik Melen

Summary: Recent evidence emphasizes the significance of optimal lung development during childhood for lifelong health. This study explored the plasticity of individual lung function states during childhood and found that catch-up and growth failure were associated with respiratory symptoms, airflow limitation, and small airway dysfunction in adulthood.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Letter Critical Care Medicine

Reply to Guo et al

Gang Wang, Jenny Hallberg, Rosa Faner, Alvar Agusti, Erik Melen

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Respiratory System

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

Alvar Agusti, Bartolome R. Celli, Gerard J. Criner, David Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, MeiLan K. Han, Fernando J. Martinez, Maria Montes de Oca, Kevin Mortimer, Alberto Papi, Ian Pavord, Nicolas Roche, Sundeep Salvi, Don D. Sin, Dave Singh, Robert Stockley, M. Victorina Lopez Varela, Jadwiga A. Wedzicha, Claus F. Vogelmeier

RESPIROLOGY (2023)

Letter Respiratory System

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19

Tamara Cruz, Nuria Mendoza, Gema M. Lledo, Lidia Perea, Nuria Albacar, Alvar Agusti, Jacobo Sellares, Oriol Sibila, Rosa Faner

ERJ OPEN RESEARCH (2023)

Letter Critical Care Medicine

Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease

Miguel Angel Martinez-Garcia, Alvar Agusti

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Critical Care Medicine

Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease

Surya P. Bhatt, Alvar Agusti, Mona Bafadhel, Stephanie A. Christenson, Jessica Bon, Gavin C. Donaldson, Don D. Sin, Jadwiga A. Wedzicha, Fernando J. Martinez

Summary: Chronic obstructive pulmonary disease is a major health problem with acute exacerbations that have limited improvements in outcomes. It is important to identify different etioendophenotypes to develop novel therapies.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Biochemistry & Molecular Biology

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression

Nuria Mendoza, Sandra Casas-Recasens, Nuria Olvera, Fernanda Hernandez-Gonzalez, Tamara Cruz, Nuria Albacar, Xavier Alsina-Restoy, Alejandro Frino-Garcia, Gemma Lopez-Saiz, Lucas Robres, Mauricio Rojas, Alvar Agusti, Jacobo Sellares, Rosa Faner

Summary: The immune response plays a controversial role in the development of idiopathic pulmonary fibrosis (IPF). This study found that IPF patients have distinct immune phenotypes in their peripheral blood, which are associated with disease severity and progression. The abnormalities in immune cell populations, particularly cytotoxic cells, are stable over time in IPF patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Cardiac & Cardiovascular Systems

Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review

Carlota Rodriguez Garcia, Alberto Ruano-Ravina, Monica Perez Rios, Lucia Martin Gisbert, Leonor Varela-Lema, Cristina Candal-Pedreira, Cristina Represas-Represas, Julia Rey-Brandariz, Luis Valdes-Cuadradoa, Alvar Agusti

Summary: Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. While smoking is a major risk factor, COPD also occurs in individuals who have never smoked (NS). However, there is limited evidence on the risk factors, clinical characteristics, and natural history of COPD in NS. This study aimed to address this knowledge gap through a systematic review of the literature.

RESPIRATORY MEDICINE (2023)

Review Cardiac & Cardiovascular Systems

When GETomics meets aging and exercise in COPD

D. Pellegrino, S. Casas-Recasens, R. Faner, P. Palange, A. Agusti

Summary: The term GETomics refers to the concept that human health and disease are the result of dynamic gene-environment interactions occurring throughout a person's lifetime. This approach has led to a dramatic shift in our understanding of chronic obstructive pulmonary disease (COPD), as it is not solely caused by smoking and affects both genders and different age groups. By applying a GETomics approach, new perspectives on the relationship between COPD, exercise limitation, and aging can be gained.

RESPIRATORY MEDICINE (2023)

Article Respiratory System

Supranormal lung function: Prevalence, associated factors and clinical manifestations across the lifespan

Caspar Schiffers, Rosa Faner, Alina Ofenheimer, Owat Sunanta, Patricia Puchhammer, Tobias Mraz, Marie-Kathrin Breyer, Otto Chris Burghuber, Sylvia Hartl, Alvar Agusti, Robab Breyer-Kohansal

Summary: This study investigated the prevalence and characteristics of individuals with supranormal FEV1 or FVC values in different age groups. It found that approximately 3% of the general population have supranormal values, which are associated with better health markers. Factors such as female sex, higher muscle mass, less diabetes, and fewer respiratory symptoms are consistently associated with supranormal values.

RESPIROLOGY (2023)

Article Cell Biology

Human senescent fibroblasts trigger progressive lung fibrosis in mice

Fernanda Hernandez-Gonzalez, Neus Prats, Valentina Ramponi, Jose Alberto Lopez-Dominguez, Kathleen Meyer, Monica Aguilera, Maria Isabel Munoz Martin, Daniel Martinez, Alvar Agusti, Rosa Faner, Jacobo Sellares, Federico Pietrocola, Manuel Serrano

Summary: Cell senescence has emerged as a potential mechanism in fibrosing interstitial lung diseases, and senescent human fibroblasts can trigger progressive fibrogenic reaction in the lungs. The secretome of senescent fibroblasts is pro-senescence and pro-fibrotic, while non-senescent fibroblasts lack these activities. Drugs like navitoclax, nintedanib, and pirfenidone can ameliorate lung fibrosis induced by senescent fibroblasts in mice.

AGING-US (2023)

Article Respiratory System

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

Erin L. Tomaszewski, Mark J. Atkinson, Christer Janson, Niklas Karlsson, Barry Make, David Price, Helen K. Reddel, Claus F. Vogelmeier, Hana Mullerova, Paul W. Jones

Summary: The Chronic Airways Assessment Test (CAAT), a questionnaire adapted for patients with asthma and/or COPD, has been shown to be consistent and accurate in measuring overall health status in these patients.

RESPIRATORY RESEARCH (2023)

No Data Available